Nouveau 16/09 Luc Marot, Président d'ADN Transition, élu administrateur de France Transition Découvrir →
New Sep 16 Luc Marot, President of ADN Transition, elected to the Board of France Transition Read more →

Interim CFO in a pharmaceutical group with 20 plants: a 12-month assignment

Finance department review and tools. Client: Group developing and manufacturing medicines for pharmaceutical companies, over €1 billion in revenue. Duration: 12 months. An interim management assignment carried out with ADN Transition.

At a glance

– Sector: Healthcare

– Client: Group developing and manufacturing medicines for pharmaceutical companies, over €1 billion in revenue

– Role of the interim manager: CFO

– Type of assignment: Transformation and project

– Duration: 12 months

What was the context?

The company develops and manufactures medicines for pharmaceutical companies. It sold 1 billion boxes in its last financial year, for revenue of over €1 billion. It runs 20 plants worldwide and has grown rapidly, mainly through acquisitions financed by several successive LBOs since 1996.

In this context of rapid growth, and following an incident with its financial partners, it wanted to review how its finance department worked, then equip it with tools to better support its growth. It asked ADN Transition to find a manager familiar with finance information systems and with how a finance department operates.

What were the key challenges?

The main challenges of the assignment were:

– Analyse the main financial processes and propose improvements;

– Review whether the department’s resources match its missions and responsibilities;

– Overhaul reporting: template, choice of tools, tender, investment case, roll-out and team support.

A similar need?

Is your company facing a similar situation? An ADN Transition partner will present 1 to 3 interim managers within 48 hours.

Contact us